KR | EN

News

Press Release

MOU with CATUG (Switzerland) for mRNA Technology Development

December 5, 2024 1

Strategic partnership signed with Switzerland's CATUG for mRNA technology development and commercialization.

Back to List

Related News

2025.09.15

MOU Signed with Cha Vaccine Institute for mRNA Vaccine Co-development
2025.05.10

MOU Signed with Affilogic (France) for Targeted Drug Development
2025.01.15

MOU with Probio (China) for mRNA Development and Production